Logo image of MWYN

MARWYNN HOLDINGS INC (MWYN) Stock Fundamental Analysis

USA - NASDAQ:MWYN - US5738631077 - Common Stock

1.26 USD
-0.05 (-3.82%)
Last: 9/22/2025, 5:57:43 PM
1.3 USD
+0.04 (+3.17%)
After Hours: 9/22/2025, 5:57:43 PM
Fundamental Rating

1

MWYN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 49 industry peers in the Trading Companies & Distributors industry. MWYN may be in some trouble as it scores bad on both profitability and health. MWYN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MWYN had negative earnings in the past year.
MWYN had a negative operating cash flow in the past year.
MWYN Yearly Net Income VS EBIT VS OCF VS FCFMWYN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 -2M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -58.89%, MWYN is doing worse than 93.88% of the companies in the same industry.
The Return On Equity of MWYN (-176.94%) is worse than 95.92% of its industry peers.
Industry RankSector Rank
ROA -58.89%
ROE -176.94%
ROIC N/A
ROA(3y)-3.76%
ROA(5y)N/A
ROE(3y)91.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MWYN Yearly ROA, ROE, ROICMWYN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 100 200 300

1.3 Margins

The Gross Margin of MWYN (21.17%) is worse than 71.43% of its industry peers.
MWYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MWYN Yearly Profit, Operating, Gross MarginsMWYN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

MWYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MWYN has been increased compared to 1 year ago.
MWYN has a better debt/assets ratio than last year.
MWYN Yearly Shares OutstandingMWYN Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 5M 10M 15M
MWYN Yearly Total Debt VS Total AssetsMWYN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 5M 10M

2.2 Solvency

Based on the Altman-Z score of 0.82, we must say that MWYN is in the distress zone and has some risk of bankruptcy.
MWYN's Altman-Z score of 0.82 is on the low side compared to the rest of the industry. MWYN is outperformed by 81.63% of its industry peers.
MWYN has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.04, MWYN is doing good in the industry, outperforming 79.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 0.82
ROIC/WACCN/A
WACC9.84%
MWYN Yearly LT Debt VS Equity VS FCFMWYN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 2M -2M 4M -4M

2.3 Liquidity

MWYN has a Current Ratio of 1.53. This is a normal value and indicates that MWYN is financially healthy and should not expect problems in meeting its short term obligations.
MWYN has a worse Current ratio (1.53) than 61.22% of its industry peers.
A Quick Ratio of 0.83 indicates that MWYN may have some problems paying its short term obligations.
With a Quick ratio value of 0.83, MWYN is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 0.83
MWYN Yearly Current Assets VS Current LiabilitesMWYN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

MWYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -590.29%.
Looking at the last year, MWYN shows a decrease in Revenue. The Revenue has decreased by -6.84% in the last year.
EPS 1Y (TTM)-590.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-520.27%
Revenue 1Y (TTM)-6.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-75.62%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MWYN Yearly Revenue VS EstimatesMWYN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MWYN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MWYN Price Earnings VS Forward Price EarningsMWYN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MWYN Per share dataMWYN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MWYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARWYNN HOLDINGS INC

NASDAQ:MWYN (9/22/2025, 5:57:43 PM)

After market: 1.3 +0.04 (+3.17%)

1.26

-0.05 (-3.82%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.1%
Inst Owner Change-14.98%
Ins Owners72.66%
Ins Owner Change0%
Market Cap21.48M
AnalystsN/A
Price TargetN/A
Short Float %8.72%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.97
P/FCF N/A
P/OCF N/A
P/B 4.32
P/tB 4.48
EV/EBITDA N/A
EPS(TTM)-0.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS1.3
BVpS0.29
TBVpS0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -58.89%
ROE -176.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.17%
FCFM N/A
ROA(3y)-3.76%
ROA(5y)N/A
ROE(3y)91.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 35.36%
Cap/Sales 0.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 0.83
Altman-Z 0.82
F-Score4
WACC9.84%
ROIC/WACCN/A
Cap/Depr(3y)119.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.44%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-590.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-520.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-75.62%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-413.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-896.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-602.69%
OCF growth 3YN/A
OCF growth 5YN/A